Reagent (chemistry) kits
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSF223201710023I
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 138 $14,843,111 obligated
Award facts
- Opportunity
-
- FDA172331180178 Solicitation number
- Reagent (Chemistry) Kits Award Notice · Posted Aug 21, 2017
- Combined order value
- $14,843,111 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 76% used
- $19,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of Reagent (Chemistry) Kits. The single-award IDC has a ceiling value of $19,500,000 and an ultimate completion date of September 14, 2022. Under this contract, the FDA has issued a series of firm fixed-price delivery orders to Illumina for the supply of various chemistry reagent kits, with individual order values ranging from $8,863.68 to $396,250.61. These orders support the FDA's analytical and testing capabilities related to reagent chemistry, likely for genomic research, molecular diagnostics, and public health surveillance applications. Illumina has previously held prime contracts with other federal agencies, including the NIH, CDC, USDA, and VA, to provide sequencing platforms, consumables, and bioinformatics products across scientific research, healthcare, and diagnostic domains.
The contract does not utilize any set-aside designations, reflecting Illumina's status as a specialized technology provider. The place of performance for all delivery orders is Illumina's facility in San Diego, California. The contract and associated task orders provide the FDA with flexible access to Illumina's proprietary reagent chemistry kits to meet evolving genomic analysis and testing needs, leveraging the company's extensive experience supporting similar requirements across the federal government.
Task orders
Show 40 more
Latest 50 of 138 listed here. See the rest on GovTribe.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSF223201710023I?
HHSF223201710023I was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 11, 2017.
How much is contract HHSF223201710023I worth?
Orders under HHSF223201710023I have obligated $14,843,111. HHSF223201710023I's own ceiling is $19,500,000.
How many orders have been placed under contract HHSF223201710023I?
138 orders have been placed under HHSF223201710023I, the latest on July 27, 2022.
Who can order from contract HHSF223201710023I?
HHSF223201710023I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSF223201710023I competed?
The extent of competition for HHSF223201710023I was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV